Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis

被引:15
作者
Sivaraman, L
Gay, J
Hilsenbeck, SG
Shine, HD
Conneely, OM
Medina, D
O'Malley, BW
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA
[4] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA
[5] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
关键词
Adv-RSV-tk/GCV; carcinogenesis; mammary gland; MNU; proliferating cells;
D O I
10.1023/A:1015227719105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Proliferating cells within the terminal end buds of the virgin female rat mammary gland are the most susceptible to chemical carcinogen induced tumorigenesis. We hypothesized that selective ablation of proliferating cells in the mammary gland would reduce mammary tumor incidence upon carcinogen challenge. Selective ablation of proliferating cells was achieved by intraductal injections of Adv-RSV-tk and gancyclovir administration. Despite efficient viral transduction of the thymidine kinase protein and the apparent elimination of >90% of the prolif-erating cells, the rats exhibited a higher incidence of MNU induced mammary tumors arising with shorter latency as compared to control animals. Several possible explanations of the puzzling relationship between elimination of cycling cells and increased tumor incidence are discussed and alternative strategies for the prevention of breast cancer are proposed.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 41 条
[31]   INHERITANCE OF HUMAN-BREAST CANCER - EVIDENCE FOR AUTOSOMAL DOMINANT TRANSMISSION IN HIGH-RISK FAMILIES [J].
NEWMAN, B ;
AUSTIN, MA ;
LEE, M ;
KING, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3044-3048
[32]   Tamoxifen to raloxifene and beyond [J].
O'Regan, RM ;
Jordan, VC .
SEMINARS IN ONCOLOGY, 2001, 28 (03) :260-273
[34]   UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years [J].
Peto, R ;
Boreham, J ;
Clarke, M ;
Davies, C ;
Beral, V .
LANCET, 2000, 355 (9217) :1822-1822
[35]  
RASMUSSEN SB, 2000, PREPARING MAMMARY GL, V1, P75
[36]   Breast cancer prevention trials [J].
Rhodes D.J. ;
Hartmann L.C. ;
Perez E.A. .
Current Oncology Reports, 2000, 2 (6) :558-565
[37]  
RUSSO J, 1980, CANCER RES, V40, P2677
[38]  
RUSSO J, 1980, AM J PATHOL, V100, P497
[39]   Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity (vol 18, pg 180, 1998) [J].
Schiedner, G ;
Morral, N ;
Parks, RJ ;
Wu, Y ;
Koopmans, SC ;
Langston, C ;
Graham, FL ;
Beaudet, AL ;
Kochanek, S .
NATURE GENETICS, 1998, 18 (03) :298-298
[40]   Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity [J].
Schiedner, G ;
Morral, N ;
Parks, RJ ;
Wu, Y ;
Koopmans, SC ;
Langston, C ;
Graham, FL ;
Beaudet, AL ;
Kochanek, S .
NATURE GENETICS, 1998, 18 (02) :180-183